The Chemours Company reported earnings of $ 0.21 per CC share on Nov 2, 2026, falling short of analysts' expectations by
| Report Date | Nov 2, 2026 |
|---|---|
| Forecasted EPS | $ 0.2662 |
| Earnings Per Share (Surprise) | $ 0.21 (-$ 0.06) |
| Last Year's EPS | $ 0.24 |
| EPS YoY Change |
Out of the last 52 earnings reporting periods, The Chemours Company beat analysts’ expectations 31 times and fell short of expectations 14 time(s). The Chemours Company reported earnings per share of $ 0.21 in the last report falling to reach an estimated EPS of $ 0.2662 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 2, 2026 | $ 0.2662 | $ 0.21 | $ 0.20 | |
| Aug 4, 2026 | $ 0.4887 | $ 0.42 | $ 0.58 | |
| May 5, 2026 | -$ 0.05 | $ 0.05 | $ 0.13 | |
| Feb 19, 2026 | $ 0.0887 | $ 0.05 | $ 0.11 | |
| Nov 6, 2025 | $ 0.24 | $ 0.20 | $ 0.40 | |
| Aug 5, 2025 | $ 0.46 | $ 0.58 | $ 0.38 | |
| May 6, 2025 | $ 0.19 | $ 0.13 | $ 0.32 | |
| Feb 18, 2025 | $ 0.10 | $ 0.11 | $ 0.31 | |
| Nov 4, 2024 | $ 0.32 | $ 0.40 | $ 0.64 | |
| Aug 1, 2024 | $ 0.57 | $ 0.38 | $ 1.10 | |
| Apr 30, 2024 | $ 0.18 | $ 0.32 | $ 0.98 | |
| Mar 27, 2024 | $ 0.29 | $ 0.31 | -$ 0.65 | |
| Oct 26, 2023 | $ 0.77 | $ 0.64 | $ 1.24 | |
| Jul 27, 2023 | $ 1.09 | $ 1.10 | $ 1.89 | |
| Apr 27, 2023 | $ 0.47 | $ 0.98 | $ 1.46 | |
| Feb 9, 2023 | $ 0.08 | -$ 0.65 | $ 0.81 | |
| Oct 25, 2022 | $ 1.04 | $ 1.24 | $ 1.27 | |
| Jul 28, 2022 | $ 1.42 | $ 1.89 | $ 1.20 | |
| May 2, 2022 | $ 0.92 | $ 1.46 | $ 0.71 | |
| Feb 10, 2022 | $ 0.87 | $ 0.81 | $ 0.61 |
The Chemours Company’s stock was trading at $ 13.53 on Nov 1, 2026 a day before the last earnings report was released.Following the release of the earnings report, CC’s price decreased to $ 13.09 on Nov 3, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 2, 2026 | $ 0.21 | $ 13.53 | $ 13.09 | |
| Aug 4, 2026 | $ 0.42 | $ 17.11 | $ 14.59 | |
| May 5, 2026 | $ 0.05 | $ 27.22 | $ 23.67 | |
| Feb 19, 2026 | $ 0.05 | $ 21.15 | $ 17.04 | |
| Nov 6, 2025 | $ 0.20 | $ 12.05 | $ 12.51 | |
| Aug 5, 2025 | $ 0.58 | $ 12.21 | $ 12.00 | |
| May 6, 2025 | $ 0.13 | $ 12.10 | $ 10.90 | |
| Feb 18, 2025 | $ 0.11 | $ 16.83 | $ 17.16 | |
| Nov 4, 2024 | $ 0.40 | $ 17.82 | $ 19.88 | |
| Aug 1, 2024 | $ 0.38 | $ 24.17 | $ 20.54 | |
| Apr 30, 2024 | $ 0.32 | $ 27.69 | $ 26.00 | |
| Mar 27, 2024 | $ 0.31 | $ 27.37 | $ 26.26 | |
| Oct 26, 2023 | $ 0.64 | $ 23.61 | $ 23.58 | |
| Jul 27, 2023 | $ 1.10 | $ 38.41 | $ 36.57 | |
| Apr 27, 2023 | $ 0.98 | $ 27.31 | $ 29.07 | |
| Feb 9, 2023 | -$ 0.65 | $ 34.94 | $ 34.35 | |
| Oct 25, 2022 | $ 1.24 | $ 28.93 | $ 29.22 | |
| Jul 28, 2022 | $ 1.89 | $ 34.22 | $ 35.59 | |
| May 2, 2022 | $ 1.46 | $ 33.07 | $ 38.91 | |
| Feb 10, 2022 | $ 0.81 | $ 36.04 | $ 30.00 |
The Chemours Company released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
The Chemours Company missed analysts’ expectations during the last earnings period by
